Hematology-Oncology

print page content

Pediatric Clinical Trials

Trials for Brain Tumors Trials for Sarcomas
Trials for Leukemia/Lymphoma Trials for Other Solid Tumors
Non-Treatment Trials  

Clinical Trials - Brain Tumors
 
  MEDULLOBLASTOMA
 
    For Information:   617-724-1836
     
 
    Protocol #:   MGH 99-271 Medullo
    Investigator:   Nancy J. Tarbell, MD
    Description:   Proton Therapy for Medulloblastoma and Other CNS Tumors –
A Prospective Look at Acute and Long-Term Sequelae
 
 
    For Information:   617-724-0857
 
    Protocol #:   COG ACNS0331
    Investigator:   David H. Ebb, MD
    Description:   Standard Risk Medulloblastoma
         
  EPENDYMOMA
         
    For Information:   617-724-0857
         
    Protocol #:   COG ACNS0121
    Investigator:   David H. Ebb, MD
    Description:   Localized Ependymomas
       

 

 
  BRAIN STEM Tumors or GLIOMAS
 
    For Information:   617-724-0857
 
    Protocol #:   COG ACNS0423
    Investigator:   David H. Ebb, MD
    Description:  

Radiation Therapy with Temozolomide and Lomustine in High Grade Gliomas

 
    For Information   617-724-0857
         
    Protocol #:   PBTC 021
    Investigator:   David H. Ebb, MD
    Description:  

Capecitabine and Radiation Therarpy in Newly Diagnosed Brain Stem and High Grade Gliomas

 
  BRAIN TUMORS - RECURRENT OR PROGRESSIVE
 
    For Information:   617-724-0857
 
    Protocol #:   PBTC 015
    Investigator:   David H. Ebb, MD
    Description:   O6-Benzylguanine and Temozolomide in Recurrent or Progressive High-Grade Gliomas or Brain Stem Gliomas
 
Back to the Top


Trials for Pediatric Leukemia/Lymphoma
 
  LEUKEMIA – Precursor B Cell
 
    For Information:   617-724-0857
 
    Protocol #:   COG AALL0331
    Investigator:   Alison M. Friedmann, MD
    Description:   Standard-Risk Acute Lymphoblastic Leukemia
 
    For Information:   617-724-0857
         
    Protocol #:   COG AALL0232
    Investigator:   Alison M. Friedmann, MD
    Description:   High-Risk Acute Lymphoblastic Leukemia
 
  HODGKIN DISEASE
 
    For Information:   617-724-0857
 
    Protocol #:   HOD99
    Investigator:   Howard J. Weinstein, MD
    Description:   Risk-Adapted Therapy in Pediatric Hodgkin Disease
 
    For Information:   617-724-0857
         
    Protocol #:   COG AHOD0121
    Investigator:   Alison M. Friedmann, MD
    Description:   Stem Cell Rescue in Refractory/Relapsed Hodgkin
     
    For Information:   617-724-0857
    Protocol #:   HOD05
    Investigator:   Alison M. Friedmann, MD
    Description:   Intermediate Risk Hodgkin Disease
         
  NON-HODGKIN LYMPHOMA
         
    For Information:   617-724-0857
         
    Protocol #:   COG ANHL01P1
    Investigator:   Howard Weinstein, MD
    Description:   Advanced B-Cell Leukemia/Lymphoma
         
 
Back to the Top


Clinical Trials - Sarcomas
 
  OSTEOSARCOMA
 
    For Information:   617-724-0857
 
    Protocol #:   COG AOST0121
    Investigator:   David H. Ebb, MD
    Description:   Trastuzumab for HER2+ Metastatic Osteosarcoma
 
  RHABDOMYOSARCOMA
 
    For Information:   617-724-0857
 
    Protocol #:   COG ARTS0331
    Investigator:   Alison M. Friedmann, MD
    Description:   Low-Risk Rhabdomyosarcoma
 
    For Information   617-724-0857
 
    Protocol #:   04-188
    Investigator:   Torunn Yock, MD
    Description:   Phase II trial of Proton Radiation for the treatment of Pediatric Rhabdomyosarcoma
 
Back to the Top


Clinical Trials - Other Solid Tumors
 
  RENAL TUMORS
 
    For Information:   617-724-0857
 
    Protocol #:   COG AREN0321
    Investigator:   Mary Huang, MD
    Description:   High Risk Renal Tumors
         
 
Non-Treatment Trials
 
  SOLID TUMORS
         
    For Information:   617-724-0857
         
    Protocol #:   ACRIN 6660
    Investigator:   Alison Friedmann,MD
    Description:   Whole-Body MRI in Pediatric Malignancies